These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 19322578)

  • 21. Cathepsin L activity and its inhibitor in human otitis media.
    Kusunoki T; Nishida S; Murata K; Kobashi K; Nakatani H; Hiwasa T; Tomura T
    J Otolaryngol; 2001 Jun; 30(3):157-61. PubMed ID: 11771045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Role of angiogenesis in the pathogenesis of cholesteatoma in adults].
    Olszewska E; Chodynicki S; Chyczewski L
    Otolaryngol Pol; 2004; 58(3):559-63. PubMed ID: 15311603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Osteoclasts are not activated in middle ear cholesteatoma.
    Koizumi H; Suzuki H; Ikezaki S; Ohbuchi T; Hashida K; Sakai A
    J Bone Miner Metab; 2016 Mar; 34(2):193-200. PubMed ID: 25796629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Theory of local inflammatory infiltration and irritation in the pathogenesis of acquired cholesteatoma].
    Zhang QA; Zhang Q; Zheng GX; Fan MY
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2005 Jan; 40(1):6-9. PubMed ID: 15906508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Role of perimatrix fibroblasts in development of acquired middle ear cholesteatoma. A hypothesis].
    Milewski C
    HNO; 1998 May; 46(5):494-501. PubMed ID: 9647920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of epithelial proliferation in paediatric and adult cholesteatomas using the Ki-67 proliferation marker.
    Sikka K; Sharma SC; Thakar A; Dattagupta S
    J Laryngol Otol; 2012 May; 126(5):460-3. PubMed ID: 22166746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The structure of acquired aural cholesteatoma as revealed by scanning electron microscopy.
    Miodoński AJ; Litwin JA; Składzień J; Zagórska-Swiezy K
    Folia Morphol (Warsz); 2008 Feb; 67(1):1-5. PubMed ID: 18335406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The significance of keratinocyte in hyperproliferation of middle ear cholesteatoma].
    Zhu Z; Hong Y; Wang Y; He G; Ye S
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jan; 30(2):139-43. PubMed ID: 27192911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gelatinolytic activity of matrix metalloproteinases 2 and 9 in middle ear cholesteatoma.
    Suchozebrska-Jesionek D; Szymański M; Kurzepa J; Gołabek W; Stryjecka-Zimmer M
    J Otolaryngol Head Neck Surg; 2008 Oct; 37(5):628-32. PubMed ID: 19128667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The methods of surgical sanation of the difficult to access parts of the middle ear in the patients presenting with chronic suppurative otitis media and concomitant cholesteatoma].
    Anikin IA; Bokuchava TA
    Vestn Otorinolaringol; 2016; 81(6):67-72. PubMed ID: 28091481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated level of tenascin and matrix metalloproteinase 9 correlates with the bone destruction capacity of cholesteatomas.
    Juhász A; Sziklai I; Rákosy Z; Ecsedi S; Adány R; Balázs M
    Otol Neurotol; 2009 Jun; 30(4):559-65. PubMed ID: 19395987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative analysis of the expression of E-cadherin, β-catenin, and β1 integrin in congenital and acquired cholesteatoma.
    Lee DW; Chung JH; Lee SH; Park CW; Kang SH; Oh YH; Pyo JY
    Eur Arch Otorhinolaryngol; 2016 Apr; 273(4):845-51. PubMed ID: 25864182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diffusion-weighted imaging for cholesteatoma evaluation.
    Schwartz KM; Lane JI; Neff BA; Bolster BD; Driscoll CL; Beatty CW
    Ear Nose Throat J; 2010 Apr; 89(4):E14-9. PubMed ID: 20397131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Current aspects of paediatric cholesteatomas].
    Thomas JP; Volkenstein S; Minovi A; Dazert S
    HNO; 2013 May; 61(5):380-7. PubMed ID: 23463409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Alterations of the basal membrane in middle ear cholesteatoma].
    Bernal Sprekelsen M; Ebmeyer J; Anonopoulos A; Borkowski G; Sudhoff H
    Acta Otorrinolaringol Esp; 2001 May; 52(4):330-5. PubMed ID: 11526629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Using surgical observations of ossicular erosion patterns to characterize cholesteatoma growth.
    Maresh A; Martins OF; Victor JD; Selesnick SH
    Otol Neurotol; 2011 Oct; 32(8):1239-42. PubMed ID: 21921854
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosis of pediatric cholesteatoma.
    Isaacson G
    Pediatrics; 2007 Sep; 120(3):603-8. PubMed ID: 17766534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Congenital cholesteatomas in Japanese--forty from our experience and fifty-five from a survey of the Japanese literature].
    Suetake M; Kobayashi T; Sasaki N; Takasaka T; Yuasa R
    Nihon Jibiinkoka Gakkai Kaiho; 1996 Sep; 99(9):1200-7. PubMed ID: 8914417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Proliferation behavior of cholesteatoma].
    Hoppe F
    HNO; 1995 Dec; 43(12):710-5. PubMed ID: 8582830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The value of scutum erosion in the diagnosis of temporal bone cholesteatoma.
    Yu Z; Han D; Gong S; Wang Z; Zhang L
    Acta Otolaryngol; 2010; 130(1):47-51. PubMed ID: 19579143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.